![Figure 4 from GLI inhibitor GANT-61 diminishes embryonal and alveolar rhabdomyosarcoma growth by inhibiting Shh/AKT-mTOR axis | Semantic Scholar Figure 4 from GLI inhibitor GANT-61 diminishes embryonal and alveolar rhabdomyosarcoma growth by inhibiting Shh/AKT-mTOR axis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/0b5272f01713825ae15c110a8ff691448ed3a200/7-Figure4-1.png)
Figure 4 from GLI inhibitor GANT-61 diminishes embryonal and alveolar rhabdomyosarcoma growth by inhibiting Shh/AKT-mTOR axis | Semantic Scholar
![GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenograft - ScienceDirect GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenograft - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0304383512006659-gr5.jpg)
GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenograft - ScienceDirect
PLOS ONE: Down-Regulation of Gli Transcription Factor Leads to the Inhibition of Migration and Invasion of Ovarian Cancer Cells via Integrin β4-Mediated FAK Signaling
![Inhibition of autophagy potentiates the efficacy of Gli inhibitor GANT-61 in MYCN-amplified neuroblastoma cells | BMC Cancer | Full Text Inhibition of autophagy potentiates the efficacy of Gli inhibitor GANT-61 in MYCN-amplified neuroblastoma cells | BMC Cancer | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2F1471-2407-14-768/MediaObjects/12885_2014_Article_4946_Fig5_HTML.jpg)
Inhibition of autophagy potentiates the efficacy of Gli inhibitor GANT-61 in MYCN-amplified neuroblastoma cells | BMC Cancer | Full Text
![JCI - Pharmacological GLI2 inhibition prevents myofibroblast cell-cycle progression and reduces kidney fibrosis JCI - Pharmacological GLI2 inhibition prevents myofibroblast cell-cycle progression and reduces kidney fibrosis](https://dm5migu4zj3pb.cloudfront.net/manuscripts/74000/74929/medium/JCI74929.f7.jpg)
JCI - Pharmacological GLI2 inhibition prevents myofibroblast cell-cycle progression and reduces kidney fibrosis
![Schematic representation of the proposed mechanism of GANT61-induced... | Download Scientific Diagram Schematic representation of the proposed mechanism of GANT61-induced... | Download Scientific Diagram](https://www.researchgate.net/profile/Svetlana-Baltic/publication/270292279/figure/fig8/AS:295184484061185@1447388873040/Schematic-representation-of-the-proposed-mechanism-of-GANT61-induced-apoptosis-in-MMe.png)
Schematic representation of the proposed mechanism of GANT61-induced... | Download Scientific Diagram
![PDF] GLI inhibitor GANT-61 diminishes embryonal and alveolar rhabdomyosarcoma growth by inhibiting Shh/AKT-mTOR axis | Semantic Scholar PDF] GLI inhibitor GANT-61 diminishes embryonal and alveolar rhabdomyosarcoma growth by inhibiting Shh/AKT-mTOR axis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/0b5272f01713825ae15c110a8ff691448ed3a200/4-Figure2-1.png)
PDF] GLI inhibitor GANT-61 diminishes embryonal and alveolar rhabdomyosarcoma growth by inhibiting Shh/AKT-mTOR axis | Semantic Scholar
![IJMS | Free Full-Text | Widespread Expression of Hedgehog Pathway Components in a Large Panel of Human Tumor Cells and Inhibition of Tumor Growth by GANT61: Implications for Cancer Therapy IJMS | Free Full-Text | Widespread Expression of Hedgehog Pathway Components in a Large Panel of Human Tumor Cells and Inhibition of Tumor Growth by GANT61: Implications for Cancer Therapy](https://www.mdpi.com/ijms/ijms-19-02682/article_deploy/html/images/ijms-19-02682-ag-550.jpg)
IJMS | Free Full-Text | Widespread Expression of Hedgehog Pathway Components in a Large Panel of Human Tumor Cells and Inhibition of Tumor Growth by GANT61: Implications for Cancer Therapy
![GLI1 inhibitor GANT61 exhibits antitumor efficacy in T-cell lymphoma cells through down-regulation of p-STAT3 and SOCS3. - Abstract - Europe PMC GLI1 inhibitor GANT61 exhibits antitumor efficacy in T-cell lymphoma cells through down-regulation of p-STAT3 and SOCS3. - Abstract - Europe PMC](https://europepmc.org/articles/PMC5564718/bin/oncotarget-08-48701-g002.jpg)